About this trial

In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.

Eligibility criteria

Qualifiers

Females

Age 18 years or older

Diagnosed with primary or recurrent EMPD of vulva and/or perianal region of the body

Willing and able to provide signed informed consent

Disqualifiers

Males

Diagnosis of Paget's Disease in body areas other than vulvar or perianal region

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

100 Participants
are grouped into 1 trial group

Locations

1
Mayo Clinic55905, RochesterMinnesota, United States

Sponsors and collaborators

Mayo Clinic

Lead sponsor